Aardvark Therapeutics Inc. Common Stock (AARD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
12.67
0.50 (4.11%)
At close: Sep 25, 2025, 3:59 PM
12.67
0.00%
After-hours: Sep 25, 2025, 04:18 PM EDT

Aardvark Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Revenue
n/a n/a n/a
Cost of Revenue
16K 97K 110K
Gross Profit
-16K -97K -110K
Operating Income
-22.79M -7.42M -11.36M
Interest Income
2.41M 1.42M 120K
Pretax Income
-20.59M -7.21M -13.56M
Net Income
-20.59M -7.21M -13.56M
Selling & General & Admin
5.3M 2.17M 2.7M
Research & Development
17.36M 4.48M 7.17M
Other Expenses
117K 762K 1.49M
Operating Expenses
22.79M 7.42M 11.36M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
22.79M 7.42M 11.36M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
12.91M 12.91M 9.73M
Shares Outstanding (Diluted)
12.91M 12.91M 9.73M
EPS (Basic)
-1.59 -0.56 -1.39
EPS (Diluted)
-1.59 -0.56 -1.39
EBITDA
-20.57M -7.32M -10.25M
EBIT
-20.59M -7.42M -10.36M
Depreciation & Amortization
16K 97K 110K